Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...

In a recent study published in The Lancet Regional Health - Europe, a group of researchers identified subpopulations at heightened risk for ST-elevation myocardial infarction (STEMI) and ...

Complete rather than culprit-only revascularization appears to pay off long-term for patients with multivessel disease presenting with non-ST-segment elevation MI (NSTEMI), suggests an observational ...

PARIS, France—Among patients with acute MI and occlusive disease on invasive angiography, those presenting without ST-segment elevation on the initial ECG fare worse than those with STEMI, researchers ...

Some clinicians say that testing for occlusion myocardial infarction (OMI) instead might be a better tool for making that determination. “We think we should get rid of the term ST-elevation MI, ...

In patients with ST-elevation myocardial infarction (STEMI) and multivessel disease, fractional flow reserve (FFR)-guided complete nonculprit revascularization did not reduce death, myocardial ...

Is there any difference in discharge instructions following percutaneous coronary intervention (PCI) for ST-elevated MI (STEMI) vs. non-STEMI (NSTEMI)? Both cases featured mild hypokinesis of the ...

Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was ...